Early TRAIL-engagement elicits potent multimodal targeting of melanoma by CD34+ progenitor cell-derived NK cellsAmanda van Vliet, Anna‐Maria Georgoudaki, Tanja D. de Gruijl et al.|iScience|2023Cited by 9
384 Single-cell transcriptomics, proteomics and in vitro cytotoxicity of allogeneic cryopreserved natural killer cell therapy GTA002 identify potent effector signaturesMonica Raimo, Jan Spanholtz, Anna‐Maria Georgoudaki et al.|Regular and Young Investigator Award Abstracts|2023Cited by 0
330 Combination therapy with stem cell derived natural killer cells and monoclonal antibodies leads to potent ADCC through engagement of endogenouse CD16Anna‐Maria Georgoudaki, Jan Spanholtz, Nina Lamers-Kok et al.|Regular and Young Investigator Award Abstracts|2023Cited by 0